Acquired thrombotic thrombocytopenic purpura: new therapeutic options and their optimal use
Author:
Affiliation:
1. Department of Medicine; Ohio State University; Columbus OH USA
2. Department of Pathology; Ohio State University; Columbus OH USA
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12934/fullpdf
Reference25 articles.
1. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis;Furlan;Blood,1996
2. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura;Moake;N Engl J Med,1982
3. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion;Tsai;Blood,1996
4. Evidence of persistent neurologic injury following thrombotic thrombocytopenic purpura;Cataland;Am J Hematol,2010
5. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura;Deford;Blood,2013
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reviewing the dysregulation of ADAMTS13 and VWF in sepsis;Shock;2023-12-12
2. Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura;BLOOD TRANSFUS-ITALY;2023
3. Effectiveness and safety of caplacizumab in acquired thrombotic thrombocytopenic purpura: health technology assessment and classification according to the methodology established in Colombia;International Journal of Technology Assessment in Health Care;2023
4. Review of our Current Understanding of ADAMTS13 and Von Willebrand Factor in Sepsis and Other Critical Illnesses;Biomarkers in Trauma, Injury and Critical Care;2023
5. Review of our Current Understanding of ADAMTS13 and Von Willebrand Factor in Sepsis and Other Critical Illnesses;Biomarkers in Trauma, Injury and Critical Care;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3